TNF and type 1 diabetes mellitus: In order to best mimic the early stages of T1D pathogenesis in vitro for our ChIP-seq and RNA-seq experiments we used a relatively low dose of IFNγ, Il-1β, and TNFα for a longer time frame than normally used (~1/64th the commonly used dosage for four days [5,34]).